Pictet Asset Management (Switzerland)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$46.3M	Sell	213,477 -31,837	-13%	-$6.82M	0.05%	300
2023 Q1	$44.6M	Buy	245,314 +15,030	+7%	+$2.87M	0.06%	304
2022 Q4	$45.3M	Buy	230,284 +106,123	+85%	+$22.8M	0.07%	290
2022 Q3	$27.9M	Buy	124,161 +4,430	+4%	+$897K	0.04%	364
2022 Q2	$15.1M	Sell	119,731 -514	-0.4%	-$59.1K	0.02%	512
2022 Q1	$15.2M	Sell	120,245 -75,585	-39%	-$8.51M	0.02%	546
2021 Q4	$25.7M	Sell	195,830 -149,541	-43%	-$19.3M	0.03%	471
2021 Q3	$42.2M	Buy	+345,371	New	+$39.9M	0.05%	368

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s KRTX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Karuna Therapeutics, Inc. Common Stock (KRTX) stake by 13% in Q2 2023, selling an estimated $6.82M and leaving 213,477 shares worth $46.3M. The position accounts for 0.05% of the portfolio, ranked #300.

Pictet Asset Management (Switzerland) first reported a position in KRTX in Q3 2021 and has held it in 8 quarters since. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

Pictet Asset Management (Switzerland) held 213,477 shares of Karuna Therapeutics, Inc. Common Stock worth $46.3M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 31,837 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $6.82M.
Karuna Therapeutics, Inc. Common Stock made up 0.05% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #300 holding.
Pictet Asset Management (Switzerland) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2021 and has held it in 8 quarters since.
289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.